Calcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-3120-41.
Published July 16, 2014 · Recall initiated: May 1, 2014
Summary
FDA records drug Class II recall D-1427-2014, published July 16, 2014 and initiated May 1, 2014. Recalling firm: Boehringer Ingelheim Roxane Inc; Status: Terminated; Reported quantity: 5364 bottles; Lot: Lot # 360122A, EXP Date: MAY 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point
What to do
Voluntary: Firm initiated
Get an email if CALCITRIOL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CALCITRIOL
- Manufacturer
- Boehringer Ingelheim Roxane Inc
- Distributor
- Nationwide
- Lot
- Lot # 360122A, EXP Date: MAY 2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufactured for: FerringJuly 16, 2014
- FDAFosphenytoin Sodium Injection, USP, 100 mg PE/2 mL (50 mg PE/mL) (PE= phenytoin sodium equivalents) 2 mLJuly 16, 2014
- FDAHeparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL),July 16, 2014
- FDAFosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mLJuly 16, 2014
- FDALabetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glassJuly 16, 2014
- FDAFluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals,July 16, 2014
Questions about this recall
Was Calcitriol Oral Solution 1 mcg/mL, 15mL bottle, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-3120-41. recalled?
Yes. FDA published recall D-1427-2014 on July 16, 2014. Reported hazard: Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CALCITRIOL.